Study Evaluating CCI-779 in Relapsing Multiple Sclerosis
Clinical trial NCT00228397 · COMPLETED
Trial details
- NCT number
- NCT00228397
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-11-01
- Primary completion
- 2005-11-01
- Enrollment
- 221
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.